NEWTON, Mass., Dec. 8, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's ...

Busy Iambic Therapeutics has picked up more than $100 million in new funding as it looks to advance its portfolio of AI-discovered therapeutics. The oversubscribed funding round comes on the heels of ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...

An artificial-intelligence-driven drug discovery platform will receive a step up onto the Nasdaq via a reverse merger with a blank check company. Nanyang Biologics has been snapped up by Nasdaq-listed ...

Ironwood Pharmaceuticals advances GI-focused medicines as Nasdaq futures discussions track broader biotech activity.